The 60 rating InvestorsObserver gives to Pieris Pharmaceuticals Inc (PIRS) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 72 percent of stocks in the Biotechnology industry, PIRS’s 60 overall rating means the stock scores better than 60 percent of all stocks.
PIRS has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on PIRS!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Pieris Pharmaceuticals Inc Stock Today?
Pieris Pharmaceuticals Inc (PIRS) stock is trading at $1.57 as of 2:19 PM on Monday, Jan 30, a drop of -$0.13, or -7.94% from the previous closing price of $1.70. The stock has traded between $1.56 and $1.72 so far today. Volume today is low. So far 148,705 shares have traded compared to average volume of 499,041 shares.
Click Here to get the full Stock Report for Pieris Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
